Cortisol inhibits cholinergic vasodilatation in the human forearm

American Journal of Hypertension - Tập 13 - Trang 1155-1160 - 2000
George J Mangos1, Brian R Walker2, John J Kelly1,3, Jane A Lawson1, David J Webb4, Judith A Whitworth5
1Department of Medicine, St. George Hospital, University of New South Wales, Kogarah, Australia (GJM, JJK, JAL)
2Endocrinology Unit, Department of Medical Sciences, University of Edinburgh, Western General Hospital, Edinburgh, UK (BRW)
3Department of Renal Medicine (JJK), St. George Hospital, University of New South Wales, Kogarah, Australia
4Department of Medicine (DJW), University of Edinburgh, Western General Hospital, Edinburgh, UK
5John Curtin School of Medical Research (JAW), Canberra, Australia

Tài liệu tham khảo

1996, Journal of hypertension, 14, S37, 10.1097/00004872-199610003-00007 Suzuki, 1992, The American journal of the medical sciences, 303, 329, 10.1097/00000441-199205000-00013 Soszynski, 1991, Journal of Endocrinology, 129, 453, 10.1677/joe.0.1290453 OBERFIELD, 1983, Journal of Clinical Endocrinology & Metabolism, 56, 332, 10.1210/jcem-56-2-332 Whitworth, 1989, Clinical endocrinology, 31, 355, 10.1111/j.1365-2265.1989.tb01259.x Walker, 1993, Clinical endocrinology, 39, 221, 10.1111/j.1365-2265.1993.tb01778.x Walker, 1996, Hypertension, 27, 190, 10.1161/01.HYP.27.2.190 Connell, 1988, Journal of hypertension, 6, 17, 10.1097/00004872-198801000-00004 Sudhir, 1989, Hypertension, 13, 416, 10.1161/01.HYP.13.5.416 1996, CLIN EXPERIMENT HYPERTENS, 19, 479 Connell, 1987, Journal of hypertension, 5, 425, 10.1097/00004872-198708000-00007 Whitworth, 1986, Clinical and experimental pharmacology & physiology, 13, 353, 10.1111/j.1440-1681.1986.tb00362.x Whitworth, 1988, Clinical and experimental pharmacology & physiology, 15, 305, 10.1111/j.1440-1681.1988.tb01078.x Turner, 1996, Hypertension, 27, 184, 10.1161/01.HYP.27.2.184 Benjamin, 1995, Hypertension, 25, 918, 10.1161/01.HYP.25.5.918 1989, Lancet, 1, 997 Calver, 1992, Journal of hypertension, 10, 1025, 10.1097/00004872-199209000-00017 1984, Clinical and experimental hypertension, 6, 795 Radomski, 1990, PNAS, 87, 10043, 10.1073/pnas.87.24.10043 1998, Cardiovascular Research, 38, 480, 10.1016/S0008-6363(98)00013-3 Gambone, 1997, British journal of pharmacology, 121, 271, 10.1038/sj.bjp.0701082 Wang, 1997, Biochemical and biophysical research communications, 233, 748, 10.1006/bbrc.1997.6548 Axelrod, 1983, Lancet, 1, 904, 10.1016/S0140-6736(83)91330-2 Hattori, 1997, Biochemical and biophysical research communications, 240, 298, 10.1006/bbrc.1997.7653 Panza, 1990, New England Journal of Medicine, 323, 22, 10.1056/NEJM199007053230105 Cockcroft, 1994, New England Journal of Medicine, 330, 1036, 10.1056/NEJM199404143301502 Williams, 1998, Circulation, 97, 1695, 10.1161/01.CIR.97.17.1695 Kelly, 1998, Clinical and experimental pharmacology & physiology, 25, 945, 10.1111/j.1440-1681.1998.tb02349.x Walker, 1998, Hypertension, 31, 891, 10.1161/01.HYP.31.4.891 Phillips, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 757, 10.1210/jc.83.3.757